Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc.

prnasiaMay 31, 2021

Tag: Nexturn , RosVivo , miRNA

PharmaSources Customer Service